Cargando…
Cladribine Tablets for Relapsing–Remitting Multiple Sclerosis: A Clinician’s Review
Multiple sclerosis (MS) is a chronic neurodegenerative disease characterized by inflammation and demyelination for which there is currently no cure; therefore, the aim of therapy is to reduce the risk of relapse and disability progression. The treatment options for MS have increased greatly in recen...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940595/ https://www.ncbi.nlm.nih.gov/pubmed/35318617 http://dx.doi.org/10.1007/s40120-022-00339-7 |